Indomethacin and Cefazolin for Physical Exam-Indicated Cerclage to Improve Latency: A Protocol Validation Study
American Journal of Perinatology · 01.08.2025 · 42 (11) · 1416-1420
DOI: 10.1055/a-2502-7225 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift American Journal of Perinatology, erschienen am 01.08.2025. Verfasst von Nicola R Young und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Duke University, Durham, North Carolina. Hauptthemen laut MEDLINE: Indomethacin, Cefazolin, Cerclage, Cervical, Tocolytic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
A single-center randomized trial showed improved latency with use of indomethacin and cefazolin (I/C) during and following exam-indicated cerclage (EIC). The same center recently published a pre/post comparison demonstrating similar results. This research aimed to validate the protocol in a different setting. Retrospective cohort study of singleton pregnancies undergoing EIC at a single center between 2013 and 2022. EIC was performed for painless cervical dilation between 16 and 23 weeks' gestation with dilation ≥1 cm. Exposure was defined as receipt of I/C during and following EIC. The primary outcome was latency ≥ 28 days after cerclage placement. Secondary outcomes included latency; gestational age at delivery; delivery ≤ 28 weeks; preterm premature rupture of membranes; intra-amniotic infection (IAI); and median birth weight. Bivariate statistics were used to analyze data; multivariable regression analyses were used to control for confounders (progesterone use, cervical dilation at time of cerclage placement, history of preterm birth, and prolapsing membranes). EIC was placed in 81 pregnancies and 48 (59%) received I/C. Baseline characteristics did not differ between groups, except that prolapsing membranes were significantly less likely in patients receiving I/C (6.2 vs. 21.2%; p = 0.04). Latency ≥ 28 days occurred in 90% of I/C recipients and 82% of the controls (p = 0.32); this difference remained nonsignificant after controlling for confounders (adjusted relative risk: 1.02 [95% confidence interval: 0.85, 1.21]). I/C recipients had lower rates of IAI (4.2 vs. 24.2%, p = 0.007), even after adjustment (adjusted relative risk: 0.18 [95% confidence interval: 0.04, 0.74]). Other secondary outcomes did not differ. Use of I/C at the time of EIC at this center was not associated with increased latency to delivery (albeit in a small cohort) but was associated with lower rates of intra-amniotic infection. Larger-scale validation studies would be helpful to confirm the value of this intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, Duke University, Durham, North Carolina.
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina.
ORCID-Profile: Nicola R Young, Luke A Gatta, Sarahn M Wheeler, Jerome J Federspiel, Sarah K Dotters-Katz
Förderung
- NICHD NIH HHS
Zitieren
APA
Young, N. R., Gatta, L. A., Wheeler, S. M., Federspiel, J. J., & Dotters-Katz, S. K. (2025). Indomethacin and Cefazolin for Physical Exam-Indicated Cerclage to Improve Latency: A Protocol Validation Study. American Journal of Perinatology, 42(11), 1416-1420. https://doi.org/10.1055/a-2502-7225
Vancouver
Young NR, Gatta LA, Wheeler SM, Federspiel JJ, Dotters-Katz SK. Indomethacin and Cefazolin for Physical Exam-Indicated Cerclage to Improve Latency: A Protocol Validation Study. American Journal of Perinatology. 2025;42(11):1416-1420. doi:10.1055/a-2502-7225
BibTeX
@article{Young2025,
author = {Young, Nicola R and Gatta, Luke A and Wheeler, Sarahn M and Federspiel, Jerome J and Dotters-Katz, Sarah K},
title = {Indomethacin and Cefazolin for Physical Exam-Indicated Cerclage to Improve Latency: A Protocol Validation Study},
journal = {American Journal of Perinatology},
year = {2025},
volume = {42},
number = {11},
pages = {1416--1420},
doi = {10.1055/a-2502-7225}
}
EUVIMED